Ondansetron ODT 4 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F20GC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,110
Award facts
- Contract value 100% obligated
- $40,109.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages) with a ceiling value of $40,109.67. This competitively awarded, firm fixed-price delivery order was issued on January 5, 2026, with an ultimate completion date of January 6, 2026. The contract involves no set-aside designation and is performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used in military and federal healthcare settings to manage nausea and vomiting associated with chemotherapy, radiation therapy, and post-operative recovery.
This delivery order operates under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen leverages this comprehensive IDC vehicle to supply medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The company's demonstrated capability to fulfill competitive federal procurement requirements across multiple therapeutic domains positions it as a critical vendor within the Defense Logistics Agency's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26F20GC?
SPE2DR26F20GC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26F20GC worth?
The government has obligated $40,110 on SPE2DR26F20GC.
Is contract SPE2DR26F20GC an order under another contract?
Yes. SPE2DR26F20GC is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F20GC competed?
The extent of competition for SPE2DR26F20GC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award